Enact Holdings, Inc.ACT

Enact Holdings, Inc. (ACT) reported $312.1M in revenue for Q1 2026, underpinned by fee-based contract underwriting services that eliminate duplicative lender and mortgage insurer processes. The company’s financials show $6.96B in assets and $549M in cash, but liabilities remain elevated at $1.62B, raising questions about capital efficiency. (source: ACT 10-Q)

ACT’s core business revolves around mortgage insurance and underwriting, with filings noting its role in expediting loan approvals through aligned standards with GSEs and FHA. However, the absence of short-term investments despite robust cash flows suggests conservative liquidity management, even as the company navigates regulatory shifts in underwriting rules. (source: ACT 10-Q)

Recent insider transactions, all filed under Rule 10b5-1(c) plans, have drawn attention. Multiple Form 4 submissions on June 23 and July 1 indicate scheduled share disposals, though the OMB approval checkbox offers little clarity on execution timing. Meanwhile, diluted EPS of $1.18 reflects share count pressures amid $224M in operating cash flow. (source: SEC EDGAR ACT 4 filings)

Chart-wise, ACT’s stock has traded in a tight range relative to its $5.34B equity base, though thin liquidity in penny-name territory (despite its size) could amplify volatility. The lack of recent earnings updates post-Q1 leaves the market reliant on regulatory filings for momentum. (source: SEC EDGAR companyfacts JSON)

Risks include regulatory changes to GSE guaranty fees or FHA pricing, which could disrupt ACT’s underwriting fee model. Liabilities exceeding $1.6B also warrant scrutiny, as do insider sales that may signal executive confidence-or lack thereof. (source: ACT 10-Q)